NCT06745284View on ClinicalTrials.gov

A Study to Test Whether Survodutide Improves How the Body Uses Energy and Breaks Down Fat in People With Obesity

PHASE1RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 26, 2025

Primary Completion Date

January 8, 2027

Study Completion Date

January 8, 2027

Conditions
Obesity
Interventions
DRUG

Survodutide

Survodutide

DRUG

Semaglutide

Semaglutide

Trial Locations (2)

32804

RECRUITING

Translational Research Institute for Metabolism and Diabetes, Orlando

70808

RECRUITING

Pennington Biomedical Research Center, Baton Rouge

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY